MoneyWorks4Me

Emmessar Biotech & Nutrition informs about board meeting outcome

09 Dec 2023 Evaluate

Emmessar Biotech & Nutrition has informed that the Board of Directors at their meeting approved and took on record the Un-Audited Financial Results for the second quarter ended September 30, 2023.

The above information is a part of company’s filings submitted to BSE.


Peers
Company Name CMP
Sun Pharma. Inds. 1743.00
Dr. Reddys Labs. 1224.50
Cipla 1337.00
Lupin 1925.00
Zydus Lifesciences 1127.85
View more..